Cargando…
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both primary and booster vaccinations. However, given...
Autores principales: | Fendler, Annika, de Vries, Elisabeth G. E., GeurtsvanKessel, Corine H., Haanen, John B., Wörmann, Bernhard, Turajlic, Samra, von Lilienfeld-Toal, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/ https://www.ncbi.nlm.nih.gov/pubmed/35277694 http://dx.doi.org/10.1038/s41571-022-00610-8 |
Ejemplares similares
-
Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022) -
COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023) -
Impfung gegen SARS-CoV-2 bei Krebspatienten
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2021) -
Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018) -
Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection
por: Neyt, Katrijn, et al.
Publicado: (2016)